Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001915598-26-000004

Chief Commercial Officer sold 226 shares at $26.28 ($5,939)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Friedl-Naderer Johanna · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-13 Sale : show line 1 in the form 10b5-1 −226 $26.28 $5,939 153,982 D
Open-market sales · 226 sh · avg $26.28 · $5,939
Loading xslF345X06/ownership.xml…